A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and to compare the efficacy and safety of a triple
modified release tacrolimus FK506E (MR4) / MMF / steroid regimen with a triple standard
tacrolimus FK506 / MMF / steroid regimen in patients undergoing kidney transplantation. It
shall be demonstrated that FK506E (MR4) is non-inferior to FK506 with regards to the primary
endpoint.